BTAI
Price
$1.18
Change
-$0.01 (-0.84%)
Updated
Jun 25 closing price
41 days until earnings call
IGMS
Price
$6.83
Change
-$0.47 (-6.44%)
Updated
Jun 25 closing price
41 days until earnings call
Ad is loading...

BTAI vs IGMS

Header iconBTAI vs IGMS Comparison
Open Charts BTAI vs IGMSBanner chart's image
BioXcel Therapeutics
Price$1.18
Change-$0.01 (-0.84%)
Volume$425.79K
CapitalizationN/A
IGM Biosciences
Price$6.83
Change-$0.47 (-6.44%)
Volume$82.35K
CapitalizationN/A
View a ticker or compare two or three
BTAI vs IGMS Comparison Chart

Loading...

BTAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IGMSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BTAI vs. IGMS commentary
Jun 26, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BTAI is a Hold and IGMS is a Hold.

COMPARISON
Comparison
Jun 26, 2024
Stock price -- (BTAI: $1.20 vs. IGMS: $7.28)
Brand notoriety: BTAI and IGMS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BTAI: 130% vs. IGMS: 28%
Market capitalization -- BTAI: $45.22M vs. IGMS: $430.87M
BTAI [@Biotechnology] is valued at $45.22M. IGMS’s [@Biotechnology] market capitalization is $430.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $630.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BTAI’s FA Score shows that 0 FA rating(s) are green whileIGMS’s FA Score has 0 green FA rating(s).

  • BTAI’s FA Score: 0 green, 5 red.
  • IGMS’s FA Score: 0 green, 5 red.
According to our system of comparison, BTAI is a better buy in the long-term than IGMS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BTAI’s TA Score shows that 3 TA indicator(s) are bullish while IGMS’s TA Score has 4 bullish TA indicator(s).

  • BTAI’s TA Score: 3 bullish, 2 bearish.
  • IGMS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BTAI is a better buy in the short-term than IGMS.

Price Growth

BTAI (@Biotechnology) experienced а -1.64% price change this week, while IGMS (@Biotechnology) price change was -0.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.70%. For the same industry, the average monthly price growth was -4.58%, and the average quarterly price growth was +47.19%.

Reported Earning Dates

BTAI is expected to report earnings on Aug 06, 2024.

IGMS is expected to report earnings on Aug 05, 2024.

Industries' Descriptions

@Biotechnology (+1.70% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BTAI with price predictions.
OPEN
A.I.dvisor published
a Summary for IGMS with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
IGMS($404M) has a higher market cap than BTAI($45.2M). IGMS YTD gains are higher at: -12.395 vs. BTAI (-59.322). BTAI has higher annual earnings (EBITDA): -139.18M vs. IGMS (-245.15M). IGMS has more cash in the bank: 294M vs. BTAI (74.1M). IGMS has less debt than BTAI: IGMS (40.9M) vs BTAI (102M). IGMS has higher revenues than BTAI: IGMS (2.11M) vs BTAI (1.76M).
BTAIIGMSBTAI / IGMS
Capitalization45.2M404M11%
EBITDA-139.18M-245.15M57%
Gain YTD-59.322-12.395479%
P/E RatioN/AN/A-
Revenue1.76M2.11M83%
Total Cash74.1M294M25%
Total Debt102M40.9M249%
FUNDAMENTALS RATINGS
BTAI: Fundamental Ratings
BTAI
OUTLOOK RATING
1..100
68
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BTAIIGMS
RSI
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
76%
Stochastic
ODDS (%)
N/A
Bullish Trend 1 day ago
81%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 29 days ago
82%
Bullish Trend 14 days ago
83%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
BTAIDaily Signal changed days agoGain/Loss if shorted
 
Show more...
IGMSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GNS0.260.01
+2.29%
Genius Group Limited
DASH112.121.42
+1.28%
DoorDash
OZK38.63-0.75
-1.90%
Bank OZK
MMI31.07-0.61
-1.93%
Marcus & Millichap
RYAM5.60-0.16
-2.78%
Rayonier Advanced Materials

IGMS and

Correlation & Price change

A.I.dvisor indicates that over the last year, IGMS has been loosely correlated with MDGL. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if IGMS jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IGMS
1D Price
Change %
IGMS100%
-0.27%
MDGL - IGMS
42%
Loosely correlated
+1.90%
BTAI - IGMS
37%
Loosely correlated
+5.70%
NTLA - IGMS
36%
Loosely correlated
+3.22%
DNA - IGMS
35%
Loosely correlated
-13.71%
ABCL - IGMS
34%
Loosely correlated
-3.45%
More